Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $1.5 million.

  • Pharma's Total Current Liabilities fell 4596.72% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 4596.72%. This contributed to the annual value of $2.3 million for FY2025, which is 354.7% down from last year.
  • As of Q3 2025, Pharma's Total Current Liabilities stood at $1.5 million, which was down 4596.72% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Pharma's Total Current Liabilities ranged from a high of $2.8 million in Q3 2024 and a low of $1.3 million during Q4 2021
  • In the last 5 years, Pharma's Total Current Liabilities had a median value of $2.1 million in 2023 and averaged $2.0 million.
  • As far as peak fluctuations go, Pharma's Total Current Liabilities surged by 5238.78% in 2023, and later plummeted by 4596.72% in 2025.
  • Over the past 5 years, Pharma's Total Current Liabilities (Quarter) stood at $1.3 million in 2021, then increased by 6.02% to $1.4 million in 2022, then surged by 42.77% to $1.9 million in 2023, then surged by 37.24% to $2.7 million in 2024, then plummeted by 43.02% to $1.5 million in 2025.
  • Its Total Current Liabilities stands at $1.5 million for Q3 2025, versus $1.7 million for Q2 2025 and $2.3 million for Q1 2025.